- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06907459
Effect of Release of Upper Track of Deep Front Facial Line Versus Myofascial Release With IASTM on Patients With Upper Cross Syndrome (UCS)
Study Overview
Status
Conditions
Detailed Description
Upper cross syndrome is a postural dysfunction that can cause a variety of upper-body musculoskeletal problems. Early detection and physiotherapy can help to prevent further complications. Maintaining bad posture over an extended duration can cause postural dysfunction and misalignment.
The first and most obvious sign of upper crossed syndrome is the characteristic postural dysfunction of protracted scapulae, medially rotated humeri, hyperkyphotic upper thoracic spine, and a protracted/ anteriorly held head, which is created by hypo lordosis or even kyphosis (excessive flexion) of the lower cervical spine, hyper lordosis of the upper cervical spine and head, and anterior translation of the head upon the atlas.
The available treatments for upper cross syndrome are Stretching, strengthening, myofascial release, postural relaxation exercise, electrical stimulations, and deep neck flexors activations are the most used techniques. Numerous studies have highlighted various benefits in terms of time efforts, and prognosis. Those are corrective exercise, Kinesio taping, scapular stabilization exercise, and PNF techniques.
Studies have demonstrated the role of fascia in various musculoskeletal dysfunctions as the fascial tissues connect the skeletal muscles forming a body-wide web in a pattern called myofascial meridians. As fascia is able to modify its tensional state, strain transmission along the meridians might occur in response to changes in muscle activity.
Deep fascia tends to be highly vascularized and contain well developed lymphatic channels. In some instances, deep fascia can even contain free encapsulated nerve endings, such as Ruffini and Pacinian corpuscles. It is present in our body in different tissue planes and in different forms with specific function and the musculoskeletal fascial system can be affected by various localized disorders with variable time course and prognosis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dokki
-
Giza, Dokki, Egypt, 11351
- Alshaymaa Shaaban Abdelazeim
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 18-40 years old
- All participants had forward head, craniovertebral angle < 50.
- All participants had rounded back (kyphosis angle ≥ 42°)
- Based on assessment of upper cross syndrome by photogrammetric analysis.
- The subjects were chosen from both genders.
Exclusion Criteria:
- History of trauma or surgery in cervical region.
- Bone fractures or acute soft tissue injuries.
- Osteoporosis.
- Heart attack.
- Unstable angina pectoris -Implanted pacemaker or defibrillator- -Cancer-
- Rheumatoid arthritis
- Connective tissue disease: This includes diseases such as osteomyelitis, lupus and scleroderma -Neurological conditions-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Upper Track of Deep Front Facial Line realese
Thirty subjects received release of upper track of deep front facial line in addition supervised corrective exercises three times a week for four weeks.
|
The MFR techniques were applied to the designated regions, with soft, steady pressure lasting 90 to 120 seconds postural correction exercises The upper track of deep front facial line release procedures were applied.
Hyoid mobilization; Larynx mobilization; Sternal oscillations; and Barral's Transversus Thoracis mobilization.
The thoracic inlet releasing ; intrathoracic fascia elongation; scalene releasing and diaphragm relaxation
The exercise program included cervical stabilization exercises performed in 3 sets of 10 repetitions with a 10-second maintenance, scapular stabilization exercises plus stretching of cervical muscles.
|
|
Experimental: Myofascial Release With IASTM
thirty subjects received myofascial release with IASTM in addition supervised corrective exercises three time a week for four weeks
|
The exercise program included cervical stabilization exercises performed in 3 sets of 10 repetitions with a 10-second maintenance, scapular stabilization exercises plus stretching of cervical muscles.
The instrument is designed to mobilize soft tissues.
Facilitation approaches were employed to break apart adhesions.
Emollient Gel/Lubrication Gel (Hawk Grips product) was also used to lubricate the skin and allow the instrument to move more easily.
The tool has two sides: one for therapy and the other for holding plus postural correction exercises
|
|
Active Comparator: supervised corrective exercises
thirty subjects received supervised corrective exercises three time a week for four weeks
|
The exercise program included cervical stabilization exercises performed in 3 sets of 10 repetitions with a 10-second maintenance, scapular stabilization exercises plus stretching of cervical muscles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
neck disability
Time Frame: up to four weeks
|
The neck disability assessment will be performed using the Neck Disability Index (NDI) questionnaire - it contains ten items that refer to neck pain (intensity) and the level of ability to manage daily living activities (personal care, reading, lifting, headache, work, concentration, driving, sleep and recreation).
The NDI score is interpreted as 0-4=no disability, 5-14=mild disability, 15-24=moderate disability, 25-34=severe disability, and over 34= total disability, where a score of 50 converted to percentiles represents 100%.
NDI score is calculated as follows: total score/total possible score, transformed to percentage multiplied by 100=% points
|
up to four weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain intensity
Time Frame: up to four weeks
|
he subject was in a relaxed position then gave him the appendix which contains VAS.
The subject was instructed to place a vertical mark on the line to indicate his/her pain.
the line has two ends; one with no pain (zero) and the other extreme pain (100 mm) at the other end
|
up to four weeks
|
|
craniovertebral angle
Time Frame: up to four weeks
|
craniovertebral angle will be measured by Photogrammetry method.
A CVA below 48-50 degrees indicates FHP
|
up to four weeks
|
|
kyphosis angle
Time Frame: up to four weeks
|
kyphosis angle will be measured by Photogrammetry method.
|
up to four weeks
|
|
upper chest expansion
Time Frame: up to four weeks
|
tape measurements will be used to measure upper chest expansion
|
up to four weeks
|
|
lower chest expansion
Time Frame: up to four weeks
|
ape measurements will be used to measure lower chest expansion
|
up to four weeks
|
|
cervical range of motion
Time Frame: up to four weeks
|
cervical range of motion device will be used to measure cervical range of motion
|
up to four weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/005666
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Upper Cross Syndrome
-
Riphah International UniversityRecruitingUpper Cross SyndromePakistan
-
Rehana HayatRecruiting
-
Ibadat International University, IslamabadRecruiting
-
Riphah International UniversityNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Riphah International UniversityRecruitingUpper Cross SyndromePakistan
-
Foundation University IslamabadActive, not recruiting
-
Foundation University IslamabadRecruiting
-
Riphah International UniversityRecruitingUpper Cross SyndromePakistan
-
Cairo UniversityNot yet recruitingUpper Cross Syndrome